These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1073 related articles for article (PubMed ID: 2928939)

  • 1. In vitro and in vivo studies of boron conjugated melanoma affined biochemicals.
    Allen BJ; Brown JK; Mountford MH; Tamat SR; Patwardhan A; Moore DE; Ichihashi M; Mishima Y; Kahl SB
    Strahlenther Onkol; 1989; 165(2-3):163-5. PubMed ID: 2928939
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement of solubility of p-boronophenylalanine by complex formation with monosaccharides.
    Yoshino K; Suzuki A; Mori Y; Kakihana H; Honda C; Mishima Y; Kobayashi T; Kanda K
    Strahlenther Onkol; 1989; 165(2-3):127-9. PubMed ID: 2928932
    [No Abstract]   [Full Text] [Related]  

  • 3. Boronated porphyrins in NCT: results with a new potent tumor localizer.
    Kahl SB; Koo MS; Laster BH; Fairchild RG
    Strahlenther Onkol; 1989; 165(2-3):134-7. PubMed ID: 2928935
    [No Abstract]   [Full Text] [Related]  

  • 4. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
    Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
    Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
    Yong JH; Barth RF; Wyzlic IM; Soloway AH; Rotaru JH
    Anticancer Res; 1995; 15(5B):2033-8. PubMed ID: 8572598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of a boronated porphyrin in murine tumors.
    Kahl SB; Laster BH; Koo MS; Warkentien LS; Fairchild RG
    Basic Life Sci; 1989; 50():205-12. PubMed ID: 2751609
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective uptake of para-boronophenylalanine increases in amelanotic melanoma cells transfected by the tyrosinase gene.
    Hiratsuka J; Kondoh H; Tsuboi T; Yoshino K; Imajo Y; Mishima Y
    Melanoma Res; 2000 Jun; 10(3):297-302. PubMed ID: 10890385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors.
    Barth RF; Yang W; Al-Madhoun AS; Johnsamuel J; Byun Y; Chandra S; Smith DR; Tjarks W; Eriksson S
    Cancer Res; 2004 Sep; 64(17):6287-95. PubMed ID: 15342417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of porphyrins in cells and tissue: synthesis of boronated porphyrins.
    Oenbrink G; Gabel D
    Strahlenther Onkol; 1989; 165(2-3):130-1. PubMed ID: 2928933
    [No Abstract]   [Full Text] [Related]  

  • 10. Boronophenylalanine for neutron capture therapy of melanoma.
    Coderre JA; Glass JD; Fairchild RG; Micca P; Kalef-Ezra J
    Strahlenther Onkol; 1989; 165(2-3):215-7. PubMed ID: 2494733
    [No Abstract]   [Full Text] [Related]  

  • 11. Biodistribution of BPA and BSH after single, repeated and simultaneous administrations for neutron-capture therapy of cancer.
    Ichikawa H; Taniguchi E; Fujimoto T; Fukumori Y
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S111-4. PubMed ID: 19376721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preloading with L-tyrosine increases the uptake of boronophenylalanine in mouse melanoma cells.
    Papaspyrou M; Feinendegen LE; Müller-Gärtner HW
    Cancer Res; 1994 Dec; 54(24):6311-4. PubMed ID: 7987818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vivo studies of a carboranyl porphyrin.
    Miura M; Gabel D; Fairchild RG; Laster BH; Warkentien LS
    Strahlenther Onkol; 1989; 165(2-3):131-4. PubMed ID: 2928934
    [No Abstract]   [Full Text] [Related]  

  • 14. Tissue distribution of para-boronophenylalanine administered orally as a cyclodextrin inclusion complex to melanoma-bearing hamsters.
    Hatanaka H; Komada F; Shiono M; Mishima Y; Okumura K
    Pigment Cell Res; 1992 Feb; 5(1):38-40. PubMed ID: 1631020
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis, antineoplastic activity and biodistribution of boron analogues of amino acids and related compounds.
    Spielvogel BF; Sood A; Hall IH; Fairchild RG; Micca PL
    Strahlenther Onkol; 1989; 165(2-3):123-5. PubMed ID: 2928931
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy.
    Liu L; Barth RF; Tjarks W; Soloway AH; Anisuzzaman AK
    Anticancer Res; 1996; 16(1):113-20. PubMed ID: 8615595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vivo biodistribution of BPA-Gd-DTPA complex as a potential MRI contrast carrier for neutron capture therapy.
    Takahashi K; Nakamura H; Furumoto S; Yamamoto K; Fukuda H; Matsumura A; Yamamoto Y
    Bioorg Med Chem; 2005 Feb; 13(3):735-43. PubMed ID: 15653341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The syntheses and in vivo biodistribution of novel boronated unnatural amino acids.
    Kabalka GW; Wu ZZ; Yao ML; Natarajan N
    Appl Radiat Isot; 2004 Nov; 61(5):1111-5. PubMed ID: 15308201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boron neutron capture therapy for undifferentiated thyroid carcinoma: preliminary results with the combined use of BPA and BOPP.
    Viaggi M; Dagrosa MA; Longhino J; Blaumann H; Calzetta O; Kahl SB; Juvenal GJ; Pisarev MA
    Appl Radiat Isot; 2004 Nov; 61(5):905-9. PubMed ID: 15308166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.